Last reviewed · How we verify
NCT06113406
Evaluation of Virtual Reality in Hazmat Training
NA trial testing Classroom Training in No Disease or Condition is Being Studied in 15 participants. Completed in 15 June 2023.
31 May 2023
Quick facts
| Lead sponsor | MetaMedia Training International, Inc. |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | other |
| Enrollment | 15 |
| Start date | 31 May 2023 |
| Primary completion | 31 May 2023 |
| Estimated completion | 15 June 2023 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Classroom Training
- Virtual Reality Training
Conditions studied
- No Disease or Condition is Being Studied — all drugs for No Disease or Condition is Being Studied →
- Evaluating a Brief Intervention — all drugs for Evaluating a Brief Intervention →
- Does Virtual Reality Aid in Hazmat Training — all drugs for Does Virtual Reality Aid in Hazmat Training →
Sponsor
MetaMedia Training International, Inc.
Who can join
Adults 18 to 65, any sex, with No Disease or Condition is Being Studied or Evaluating a Brief Intervention. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Type of study: Two-group comparison. Main question it aims to answer: Does the use of virtual reality emergency scenarios provide a practical and effective tool to supplement traditional instructor-led training for first responder trainees? A. For the traditional hazmat response training group; Traditional training will be held in the classroom environment for 45 minutes in the form of a lecture, then the training session will be terminated. B. For VR hazmat response training group; After the traditional classroom session has ended, the participants will complete the additional VR training scenario, online content, and question-answer session. Once completed the session will be closed.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06113406
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for No Disease or Condition is Being Studied
Currently open trials in the same condition.
- NCT06638996 — Acute Psychological and Physiological Effects of Cannabigerol · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06113406 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by MetaMedia Training International, Inc.
- Last refreshed: 2 November 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06113406.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing